FedEx (NYSE:FDX): Oppenheimer is expecting the company’s fourth quarter EPS to fall at the bottom half of its guidance range, but thinks that the company’s adjusted EPS can rise about 20 percent in FY14. It keeps an Outperform rating on the shares.
Groupon (NASDAQ:GRPN): Morgan Stanley believes that it is seeing the early stages of a turnaround at the company, and thinks that Groupon can sustain Q1 North American momentum as customer growth remains healthy and mobile and pull distribution drive growth. The firm points out that international is better, but remains an overhang. Shares are Equal Weight rated.
Monster Beverage (NASDAQ:MNST): Goldman sees the weakness in shares following American Medical Association reports that it may endorse a ban on sales and marketing of energy drinks as being overdone, as the firm says the proposal does not contain new information and the AMA requested additional studies to better understand the issue.
Health Management (NYSE:HMA): Wells Fargo has raised its price target on Health Management to $16-$24 from $13.50-$16, based on reflections of what it thinks would be the upper end of the range that an acquirer of the company would be willing to pay. The firm believes that the stock’s recent appreciation indicates that a deal has become more likely, and it keeps an Outperform rating on the shares.